La Pampa expondrá a la comunidad científica los resultados del Programa de Intervención Monitoreado de Ivermectina

La Pampa, Argentina

Aug 2021

Source PDF All Studies Meta AnalysisMeta

News report on the use of ivermectin in La Pampa, Argentina, showing lower mortality with treatment. This study is excluded in the after exclusion results of meta analysis: minimal details provided.

Important missing comments or errors? Let us know.

risk of death, 27.4% lower, RR 0.73, treatment 3,269, control 18,149.

risk of death/ICU, 38.0% lower, RR 0.62, treatment 3,269, control 18,149.

risk of death, 33.4% lower, RR 0.67, treatment 3,269, control 18,149, >40yo.

risk of death, 44.0% lower, RR 0.56, treatment 3,269, control 18,149, >40yo including comorbidities.

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

La Pampa et al., 10 Aug 2021, retrospective, Argentina, preprint, 1 author, dosage 600μg/kg days 1-5.

All Studies Meta Analysis Submit Updates or Corrections

This Paper Ivermectin All

Download Image

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

@CovidAnalysis

FAQ

Public domain CC0 1.0